Subsequent ChIP assay showed that the chromatin fragment corresponding to the assumed EGR1 binding site (BS1) was specific in anti‐EGR1 immunoprecipitate of osteosarcoma cells, and the binding was enhanced after treatment with Scutellarin (Figure 4L). This evidence concerns the gene EGR1 and osteosarcoma.